• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗前的痛苦预示着延迟性而非急性恶心。

Distress before chemotherapy predicts delayed but not acute nausea.

作者信息

Higgins Sara C, Montgomery Guy H, Bovbjerg Dana H

机构信息

Biobehavioral Medicine Program, Department of Oncological Sciences, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.

出版信息

Support Care Cancer. 2007 Feb;15(2):171-7. doi: 10.1007/s00520-006-0113-y. Epub 2006 Aug 3.

DOI:10.1007/s00520-006-0113-y
PMID:16896879
Abstract

INTRODUCTION

Posttreatment nausea (PTN) is a common side effect of cytotoxic cancer chemotherapy. Previous retrospective research has suggested that the severity of PTN may be, in part, related to pretreatment psychological factors (e.g., emotional distress and expectations for nausea).

MATERIALS AND METHODS

The purpose of the present study was to examine these relationships prospectively, with distress and nausea expectations assessed by validated self-report measures completed in the clinic before the participants' first outpatient treatment infusion and with PTN (0-100) assessed by end-of-day diaries completed at home on each of the first 5 days after treatment. The participants were chemotherapy-naive women (N=56) scheduled for standard adjuvant treatment for stage I-II breast cancer (mean age=45.6 years). PTN was evaluated for acute (days 0-1) and delayed (days 2-5) responses.

RESULTS

The results revealed a significant relationship between pretreatment distress and the severity of the patients' subsequent delayed nausea (p<0.007) but not a relationship with acute PTN (p<0.19). No significant relationships were seen between expectations and PTN. However, there was evidence of an additive effect of nausea expectations and distress, with the highest levels of delayed PTN seen in patients with both expectations and higher distress before treatment. The results suggest a selective effect of pre-infusion psychological variables on the delayed phase of nausea after chemotherapy, consistent with an emerging view that the different phases of nausea are mediated by different neural pathways.

CONCLUSION

Future research should examine the possibility that delayed nausea, which the literature suggests is more resistant to antiemetic drugs than acute nausea, might be responsive to psychological interventions before initial treatments.

摘要

引言

治疗后恶心(PTN)是细胞毒性癌症化疗常见的副作用。以往的回顾性研究表明,PTN的严重程度可能部分与治疗前的心理因素有关(例如,情绪困扰和对恶心的预期)。

材料与方法

本研究的目的是前瞻性地研究这些关系,通过在参与者首次门诊治疗输液前在诊所完成的经过验证的自我报告测量方法评估困扰和恶心预期,并通过治疗后前5天每天在家中完成的每日结束时日记评估PTN(0-100)。参与者为计划接受I-II期乳腺癌标准辅助治疗的初治化疗女性(N=56)(平均年龄=45.6岁)。评估PTN的急性(第0-1天)和延迟(第2-5天)反应。

结果

结果显示,治疗前困扰与患者随后延迟性恶心的严重程度之间存在显著关系(p<0.007),但与急性PTN无关系(p<0.19)。预期与PTN之间未发现显著关系。然而,有证据表明恶心预期和困扰存在相加效应,在治疗前既有预期又有较高困扰的患者中延迟性PTN水平最高。结果表明输液前心理变量对化疗后恶心延迟期有选择性影响,这与一种新出现的观点一致,即恶心的不同阶段由不同的神经通路介导。

结论

未来的研究应探讨延迟性恶心(文献表明其比急性恶心更难用止吐药治疗)在初始治疗前可能对心理干预有反应的可能性。

相似文献

1
Distress before chemotherapy predicts delayed but not acute nausea.化疗前的痛苦预示着延迟性而非急性恶心。
Support Care Cancer. 2007 Feb;15(2):171-7. doi: 10.1007/s00520-006-0113-y. Epub 2006 Aug 3.
2
Expectations of chemotherapy-related nausea: emotional and experiential predictors.
Ann Behav Med. 2003 Winter;25(1):48-54. doi: 10.1207/S15324796ABM2501_07.
3
Nonpharmacologic factors in the development of posttreatment nausea with adjuvant chemotherapy for breast cancer.
Cancer. 1988 Jan 15;61(2):379-85. doi: 10.1002/1097-0142(19880115)61:2<379::aid-cncr2820610230>3.0.co;2-e.
4
Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.预测化疗相关恶心和呕吐的风险因素评估:一项欧洲前瞻性观察性研究的结果
J Pain Symptom Manage. 2014 May;47(5):839-848.e4. doi: 10.1016/j.jpainsymman.2013.06.012. Epub 2013 Sep 24.
5
Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.接受辅助多柔比星和环磷酰胺治疗的乳腺癌患者化疗引起恶心和呕吐的临床预测因素。
Ann Pharmacother. 2009 Mar;43(3):444-52. doi: 10.1345/aph.1L437. Epub 2009 Feb 3.
6
Chemotherapy-induced nausea, vomiting, and fatigue--the role of individual differences related to sensory perception and autonomic reactivity.化疗引起的恶心、呕吐和疲劳——与感觉知觉和自主反应性相关的个体差异的作用。
Psychother Psychosom. 2007;76(6):376-84. doi: 10.1159/000107566.
7
Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study.心理社会变量对癌症患者化疗引起的恶心和呕吐及健康相关生活质量的作用:一项欧洲研究。
Psychother Psychosom. 2015;84(6):339-47. doi: 10.1159/000431256. Epub 2015 Sep 24.
8
Treatment related psychological distress during adjuvant chemotherapy as a conditioned response.
Ann Oncol. 1992 May;3(5):393-8. doi: 10.1093/oxfordjournals.annonc.a058214.
9
The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomised controlled trial.渐进性肌肉松弛训练对中国乳腺癌患者化疗所致恶心和呕吐的管理效果:一项随机对照试验。
Support Care Cancer. 2002 Apr;10(3):237-46. doi: 10.1007/s00520-001-0329-9. Epub 2001 Dec 18.
10
Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs. patients' reported outcomes.台湾地区化疗引起的恶心和呕吐发生率:医生和护士的估计与患者报告的结果对比
Support Care Cancer. 2005 May;13(5):277-86. doi: 10.1007/s00520-005-0788-5. Epub 2005 Mar 16.

引用本文的文献

1
Delayed Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Incidence, and Current Management.延迟性化疗引起的恶心和呕吐:发病机制、发生率及当前管理
Front Pharmacol. 2017 Jan 30;8:19. doi: 10.3389/fphar.2017.00019. eCollection 2017.
2
Integrative review of factors related to the nursing diagnosis nausea during antineoplastic chemotherapy.抗肿瘤化疗期间与护理诊断恶心相关因素的综合综述
Rev Lat Am Enfermagem. 2016 Oct 10;24:e2812. doi: 10.1590/1518-8345.1176.2812.
3
Getting the grip on nonspecific treatment effects: emesis in patients randomized to acupuncture or sham compared to patients receiving standard care.

本文引用的文献

1
5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial.5-羟色胺受体拮抗剂与丙氯拉嗪用于控制阿霉素所致延迟性恶心的疗效比较:一项URCC CCOP随机对照试验
Lancet Oncol. 2005 Oct;6(10):765-72. doi: 10.1016/S1470-2045(05)70325-9. Epub 2005 Sep 13.
2
Update on anti-emetics for chemotherapy-induced emesis.
Intern Med J. 2005 Aug;35(8):478-81. doi: 10.1111/j.1445-5004.2005.00879.x.
3
A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale (LCSS): does format affect patient ratings of symptoms and quality of life?肺癌症状量表(LCSS)视觉模拟评分法与数字评定量表格式的比较:量表格式会影响患者对症状及生活质量的评分吗?
把握非特异性治疗效果:与接受标准治疗的患者相比,随机接受针刺或假针刺的患者的呕吐情况。
PLoS One. 2011 Mar 23;6(3):e14766. doi: 10.1371/journal.pone.0014766.
4
Effect of pretreatment distress on daily fatigue after chemotherapy for breast cancer.预处理困扰对乳腺癌化疗后日常疲劳的影响。
J Oncol Pract. 2008 Mar;4(2):59-63. doi: 10.1200/JOP.0822002.
5
Ethnicity and persistent symptom burden in breast cancer survivors.乳腺癌幸存者的种族与持续症状负担。
J Cancer Surviv. 2009 Dec;3(4):241-50. doi: 10.1007/s11764-009-0100-7. Epub 2009 Oct 27.
6
A meta-analysis of the relationship between response expectancies and cancer treatment-related side effects.一项关于预期反应与癌症治疗相关副作用之间关系的荟萃分析。
J Pain Symptom Manage. 2009 Nov;38(5):775-84. doi: 10.1016/j.jpainsymman.2009.01.008. Epub 2009 Sep 23.
7
Self-reported taste and smell changes during cancer chemotherapy.癌症化疗期间自我报告的味觉和嗅觉变化。
Support Care Cancer. 2008 Mar;16(3):275-83. doi: 10.1007/s00520-007-0319-7. Epub 2007 Aug 21.
Qual Life Res. 2005 Apr;14(3):837-47. doi: 10.1007/s11136-004-0833-8.
4
The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.口服NK(1)拮抗剂阿瑞匹坦预防化疗引起的急性和迟发性恶心与呕吐:两项随机、双盲、安慰剂对照试验的汇总数据
Eur J Cancer. 2005 Jun;41(9):1278-85. doi: 10.1016/j.ejca.2005.01.024.
5
Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.阿瑞匹坦预防中度致吐性化疗后乳腺癌患者化疗引起的恶心和呕吐的疗效及耐受性
J Clin Oncol. 2005 Apr 20;23(12):2822-30. doi: 10.1200/JCO.2005.09.050.
6
Nausea: the neglected symptom?恶心:被忽视的症状?
Eur J Oncol Nurs. 2005 Mar;9(1):21-32. doi: 10.1016/j.ejon.2004.03.006.
7
Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer.化疗副作用的排名及症状评估:来自卵巢癌经验丰富患者的见解
Support Care Cancer. 2005 Apr;13(4):219-27. doi: 10.1007/s00520-004-0710-6. Epub 2004 Nov 9.
8
Patient expectation is a strong predictor of severe nausea after chemotherapy: a University of Rochester Community Clinical Oncology Program study of patients with breast carcinoma.患者期望是化疗后严重恶心的有力预测指标:罗切斯特大学社区临床肿瘤项目对乳腺癌患者的研究。
Cancer. 2004 Dec 1;101(11):2701-8. doi: 10.1002/cncr.20718.
9
Chemotherapy-related nausea and vomiting - past reflections, present practice and future management.化疗相关的恶心与呕吐——过去的思考、当前的实践及未来的管理
Eur J Cancer Care (Engl). 2004 Mar;13(1):71-81. doi: 10.1111/j.1365-2354.2004.00446.x.
10
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.口服神经激肽-1拮抗剂阿瑞匹坦预防化疗引起的恶心和呕吐:一项针对接受高剂量顺铂治疗患者的多国、随机、双盲、安慰剂对照试验——阿瑞匹坦方案052研究组
J Clin Oncol. 2003 Nov 15;21(22):4112-9. doi: 10.1200/JCO.2003.01.095. Epub 2003 Oct 14.